[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE237336T1 - Stabile suppositorienformulierung von delta-9-thc (tetrahydrocannabinol) - Google Patents

Stabile suppositorienformulierung von delta-9-thc (tetrahydrocannabinol)

Info

Publication number
ATE237336T1
ATE237336T1 AT94917418T AT94917418T ATE237336T1 AT E237336 T1 ATE237336 T1 AT E237336T1 AT 94917418 T AT94917418 T AT 94917418T AT 94917418 T AT94917418 T AT 94917418T AT E237336 T1 ATE237336 T1 AT E237336T1
Authority
AT
Austria
Prior art keywords
delta
thc
tetrahydrocannabinol
suppository formulation
stable suppository
Prior art date
Application number
AT94917418T
Other languages
English (en)
Inventor
Mahmoud A Elsohly
Original Assignee
Univ Mississippi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mississippi filed Critical Univ Mississippi
Application granted granted Critical
Publication of ATE237336T1 publication Critical patent/ATE237336T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94917418T 1993-05-21 1994-05-17 Stabile suppositorienformulierung von delta-9-thc (tetrahydrocannabinol) ATE237336T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/065,117 US5389375A (en) 1993-05-21 1993-05-21 Stable suppository formulations effecting bioavailability of Δ9 -thc
PCT/US1994/005512 WO1994027533A1 (en) 1993-05-21 1994-05-17 Stable suppository formulations effecting biovailability of δ9-thc

Publications (1)

Publication Number Publication Date
ATE237336T1 true ATE237336T1 (de) 2003-05-15

Family

ID=22060436

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94917418T ATE237336T1 (de) 1993-05-21 1994-05-17 Stabile suppositorienformulierung von delta-9-thc (tetrahydrocannabinol)

Country Status (11)

Country Link
US (2) US5389375A (de)
EP (1) EP0752838B1 (de)
JP (1) JPH08510741A (de)
KR (1) KR100354403B1 (de)
AT (1) ATE237336T1 (de)
CA (1) CA2163363C (de)
DE (1) DE69432527T2 (de)
DK (1) DK0752838T3 (de)
MX (1) MX9403799A (de)
PL (1) PL175113B1 (de)
WO (1) WO1994027533A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132762A (en) * 1997-05-05 2000-10-17 Cristobal; Walter Transcutaneous application of marijuana
US5847128A (en) * 1998-05-29 1998-12-08 Virginia Commonwealth University Water soluble derivatives of cannabinoids
WO2000045813A1 (en) * 1999-02-04 2000-08-10 New Millennium Pharmaceutical Research, Inc. Method for enhancement of delivery of thc by the administration of its prodrugs via the nasal route
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
WO2000056303A2 (en) 1999-03-22 2000-09-28 Immugen Pharmaceuticals, Inc. Treatment of immune diseases
US6747058B1 (en) 1999-08-20 2004-06-08 Unimed Pharmaceuticals, Inc. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
US7648696B2 (en) * 1999-08-20 2010-01-19 Unimed Pharmaceuticals, Llc Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
EP1321159A1 (de) * 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Betätigungsvorrichtung für Druckdosierinhalator mit lasergebohrten Löchern
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
WO2006007734A1 (de) * 2004-07-19 2006-01-26 Cilag Ltd. Verfahren zur gewinnung von reinem tetrahydrocannabinol
TWI369203B (en) 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
US8628796B2 (en) * 2004-12-09 2014-01-14 Insys Therapeutics, Inc. Room-temperature stable dronabinol formulations
TWI366460B (en) * 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
EP2578577A1 (de) 2005-09-29 2013-04-10 Albany Molecular Research, Inc. Sulfonylester von Tetrahydrocannabinol und dessen Derivaten
BRPI0715328A2 (pt) * 2006-08-04 2013-07-09 Insys Therapeutics Inc formulaÇço, e, dispositivo de dose unitÁria ou de dose méltipla para a administraÇço sublingual de uma droga
WO2008139263A2 (en) * 2006-11-30 2008-11-20 University Of Plymouth Methods for slowing the progression of multiple sclerosis
US20080181942A1 (en) * 2006-11-30 2008-07-31 University Of Plymouth Delta-9-THC compositions and methods for treating symptoms associated with multiple sclerosis
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
MX2010001242A (es) * 2007-07-30 2010-07-02 Alltranz Inc Profarmacos de canabidiol, composiciones que comprenden profarmacos de canabidiol y metodos para utilizar los mismos.
EP2184983A1 (de) * 2007-08-06 2010-05-19 Insys Therapeutics Inc. Orale cannabinoid-flüssigformulierungen und behandlungsverfahren
US8227627B2 (en) * 2007-11-30 2012-07-24 Alltranz Inc. Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
JP5518418B2 (ja) * 2008-10-06 2014-06-11 第一三共ヘルスケア株式会社 坐薬製剤組成物
CA2741862C (en) * 2008-10-31 2017-10-17 Mahmoud A. Elsohly Compositions containing delta-9-thc-amino acid esters and process of preparation
WO2018075730A1 (en) * 2016-10-21 2018-04-26 Axim Biotechnologies, Inc. Suppositories comprising cannabinoids
WO2019049142A1 (en) 2017-09-08 2019-03-14 Scicann Therapeutics Inc. COMPOSITIONS COMPRISING CANNABINOID AND SPILANTHOL
CA3096547A1 (en) * 2018-04-13 2019-10-17 Urban Juve Provisions Inc. Cannabis root extract, method of manufacture, method of use
US10751299B2 (en) * 2018-09-04 2020-08-25 Babak Ghalili Cannabinoid and menthol compositions and methods
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728360A (en) * 1971-08-31 1973-04-17 Little Inc A Ester derivatives of tetrahydrocannabinol
US4933363A (en) * 1988-08-16 1990-06-12 Elsohly Mahmoud A Method for effecting systemic delivery of delta-9-tetrahydrocannabinol

Also Published As

Publication number Publication date
DE69432527D1 (de) 2003-05-22
WO1994027533A1 (en) 1994-12-08
AU6915194A (en) 1994-12-20
MX9403799A (es) 1997-02-28
EP0752838B1 (de) 2003-04-16
AU689110B2 (en) 1998-03-26
JPH08510741A (ja) 1996-11-12
KR100354403B1 (ko) 2002-12-26
EP0752838A1 (de) 1997-01-15
US5508037A (en) 1996-04-16
CA2163363A1 (en) 1994-12-08
PL311706A1 (en) 1996-03-04
DK0752838T3 (da) 2003-08-11
US5389375A (en) 1995-02-14
DE69432527T2 (de) 2004-04-08
PL175113B1 (pl) 1998-11-30
EP0752838A4 (de) 1996-05-30
CA2163363C (en) 2007-01-30

Similar Documents

Publication Publication Date Title
ATE237336T1 (de) Stabile suppositorienformulierung von delta-9-thc (tetrahydrocannabinol)
DK0486499T3 (da) Stabile sammensætninger af ascorbinsyre
ES2168414T3 (es) Formulaciones de retinoides en microesferas porosas de irritacion reducida y estabilidad aumentada.
DK0656774T3 (da) Kosmetiske og dermatologiske lysbeskyttelsesformuleringer med et indhold af thioler og/eller thiolderivater
DK0812198T3 (da) Stabilisering af prostaglandinpræparater
DK0650483T3 (da) (3R,4R)-Delta6-tetrahydrocannabinol-7-syrer
DK0578077T3 (da) Præparater, der indeholder retinsyrer og tocopherol
AU6022890A (en) Diarylacetylenes, the preparations and use thereof
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
DK0641343T3 (da) 4-Mercaptoacetylamino-[2]benzazepinon(3)-derivater og anvendelse som enkefalinaseinhibitorer
MX9207074A (es) Piperazinil- y piperidinil -ciclohexanoles y composicion farmaceutica que los comprende
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
ATE98675T1 (de) Wasserstoffperoxid enthaltende stabile bleichmittelzusammensetzungen.
FI923752A0 (fi) Benso(f)kinolinoner.
MX9204563A (es) Nuevos derivados de la (2-alquil-3-piridil)-metilpiperazina y composicion farmaceutica que los comprende.
ES2045484T3 (es) Nuevos derivados de la vitamina d: aplicaciones terapeuticas y a las dosificaciones de los metabolitos de la vitamina d.
ES2153835T3 (es) Formulaciones farmaceuticas estables a base de nicorandil.
DK0727996T3 (da) Fendazolformuleringer
NO304874B1 (no) Anvendelse av kolesterolnedsettende tokoferolanaloger
DK1156829T3 (da) Stabil formulering indeholdende fumagillin
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
MX9400068A (es) Metodo para estabilizar ditionito de sodio.
DK0597414T3 (da) Stabil formulering af sennaekstrakt
ITPD930045A0 (it) Nuovi derivati o-solfatati di gangliosidi e lisogangliosidi
SU1814475A1 (ru) Состав для пассивного лазерного затвора блочного типа

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties